Due to the significant business growth in its Surgical Services department, MPI Research is announcing the purchase of a large swine facility to house multiple species of research and colony animals, from micro and mini up to farm pigs. Swine have long been the preferred model for many medical device researchers, as well as other surgical and dermal toxicology studies. MPI Research has been a leader in providing preclinical surgical research, ranging from orthopedic and spinal models to vascular stents for the pharmaceutical and medical device industries. The addition of the new swine facility documents the unrelenting commitment of MPI Research to continue to hold a leadership position with this increasingly important research species.

The new facility, located near the main MPI Research facility in Mattawan, MI, is a fully GLP compliant housing facility with industry standard Provantis TM electronic data capture system. With the capacity to house up to 200 animals, this new addition gives MPI Research the competitive advantage of having swine readily available to initiate surgical or medical device studies quickly. Mini and micro pigs are often in short supply; therefore MPI Research has regular standing orders with major suppliers of both. The maintenance of ready stock colonies is of great benefit to MPI Research Sponsors, none of whom can afford to wait for animal availability to initiate critical preclinical studies.

William Harrison, President and Chief Operating Officer commented, “This is an important step for our surgical program. This gives us the ability to start swine studies faster than our competitors without tying up valuable animal rooms at our main facility, allowing greater response time to our Sponsors. This is consistent with our previous commitment to maintain colonies of ready nonhuman primates and other large animals, allowing MPI Research to start studies faster than our competitors. This always has been, and will continue to be our promise to our customers.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, medical device, animal health and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world. MPI Research employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, experimental therapeutics, immunotoxicology, analytical chemistry, computer science, regulatory science, and statistics.

Home | News